- NZ$1.62bn
- NZ$4.20bn
- NZ$689.89m
- 57
- 94
- 31
- 64
Annual income statement for Ryman Healthcare, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | R2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | Interim Report |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 424 | 456 | 509 | 571 | 690 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 378 | 428 | 502 | 591 | 728 |
| Operating Profit | 46 | 28.1 | 6.86 | -19.9 | -38.6 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 171 | 411 | 722 | 206 | -186 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 265 | 423 | 693 | 258 | -78.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 265 | 423 | 693 | 258 | -78.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 265 | 423 | 693 | 258 | -78.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.341 | 0.558 | 0.894 | 0.331 | -0.077 |
| Dividends per Share |